The second part of our Exclusive Distribution episode continues the conversation with Donovan Quill, Executive Vice President of Business Development, Growth & Strategy at AscellaHealth and Charlie Gayer, Chief Commercial Officer at BioCryst, as they discuss the advantages of using a sole-source, exclusive distribution and specialty fulfillment partner; including increased efficiency, centralized data, and delivering enhanced personalized patient support.
About AscellaHealth
Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.
We’re here to change that.
Because at AscellaHealth, we believe that all patients in need should have the ability to access life-changing therapies.
Our Core Beliefs
At AscellaHealth, patients are not just part of the process—they’re why we do what we do. Every solution we build and every partnership we form is designed with the patient in mind.
Patients First, Always.
Balancing Cost and Care.
Better Stakeholder Outcomes.